Professor of Medicine, Johns Hopkins University School of Medicine; Director, Division of General Internal Medicine
Internal Medicine
Dr. Jeanne M. Clark, MD
|
|
Give Review
Jeanne M. Clark, MD practices Internal Medicine. She studied medicine at Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification". Jeanne M. Clark has written publications. She has 100 publications published with PubMed. The lastest paper is: 'Effectiveness of an Activity Tracker- and Internet-Based Adaptive Walking Program for Adults: A Randomized Controlled Trial.'
Publications
- Sex Differences Among Career Development Awardees in the Attainment of Independent Research Funding in a Department of Medicine.
- Willingness to pay for continued delivery of a lifestyle-based weight loss program: The Hopkins POWER trial.
- Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish.
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
- Aging and Physical Function in Type 2 Diabetes: 8 Years of an Intensive Lifestyle Intervention.
- Prior doctor shopping resulting from differential treatment correlates with differences in current patient-provider relationships.
- Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese.
- Prepregnancy body mass index and cardiovascular disease mortality: The child health and development studies.
- Utilization of Primary and Obstetric Care After Medically Complicated Pregnancies: An Analysis of Medical Claims Data.
- Laboratory Testing for and Diagnosis of Nutritional Deficiencies in Pregnancy Before and After Bariatric Surgery.
- Insights from the POWER Practice-Based Weight Loss Trial: A Focus Group Study on the PCP's Role in Weight Management.
- Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
- Meta-analysis: vitamin D and non-alcoholic fatty liver disease.
- Early Response to Preventive Strategies in the Diabetes Prevention Program.
- Change in claims-based diabetes medications is a diabetes improvement indicator.
- Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
- Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data.
- Intensive Weight Loss Intervention in Older Individuals: Results from the Action for Health in Diabetes Type 2 Diabetes Mellitus Trial.
- A Screening Tool to Assess and Manage Behavioral Risk in the Postoperative Bariatric Surgery Patient: The WATCH.
- The long-term effectiveness of a lifestyle intervention in severely obese individuals.
- Screening and Diagnosis of Micronutrient Deficiencies Before and After Bariatric Surgery.
- Racial differences in nonalcoholic fatty liver disease in the U.S. population.
- Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B with Ultrasound-Defined Steatosis Based on Data from the NHANES III.
- Association of an intensive lifestyle intervention with remission of type 2 diabetes.
- Effect of exercise on blood pressure in type 2 diabetes: a randomized controlled trial.
- Changes in weight and health behaviors after pregnancies complicated by gestational diabetes mellitus: The CARDIA study.
- Doctor shopping by overweight and obese patients is associated with increased healthcare utilization.
- Body Mass Index and Colon Cancer Screening: A Systematic Review and Meta-Analysis.
- Impact of bariatric surgery on health care utilization and costs among patients with diabetes.
- Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice.
- Development and Validation of a Model for Predicting Inpatient Hospitalization.
- Low Glycated Hemoglobin and Liver Disease in the U.S. Population.
- Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans?
- Four-year weight losses in the Look AHEAD study: factors associated with long-term success.
- The association of arterial shear and flow-mediated dilation in diabetes.
- Risk of complications after bariatric surgery among individuals with and without type 2 diabetes mellitus.
- The Impact of Obesity on Breast Surgery Complications.
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis.
- Surgical Site Infections and Cost in Obese Patients Undergoing Colorectal Surgery.
- Morbidity Trajectories as Predictors of Utilization: Multi-year Disease Patterns in Taiwan's National Health Insurance Program.
- Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
- Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study.
- Disparity in physician perception of patients' adherence to medications by obesity status.
- Reduced incidence of gestational diabetes with bariatric surgery.
- Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery.
- Development of a claims-based risk score to identify obese individuals.
- Trends in and patterns of obesity reduction medication use in an insured cohort.
- Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
- Physician respect for patients with obesity.
- Effect of gastric bypass surgery on kidney stone disease.
- Obesity and mammography: a systematic review and meta-analysis.
- Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.
- The association of obesity and cervical cancer screening: a systematic review and meta-analysis.
- Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?
- The epidemiology of nonalcoholic fatty liver disease: a global perspective.
- The effect of a probiotic on hepatic steatosis.
- Brief communication: clinical implications of short-term variability in liver function test results.
- A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
- Lifetime weight patterns in male physicians: the effects of cohort and selective survival.
- Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence.
- The epidemiology of nonalcoholic fatty liver disease in adults.
- Weight loss as a treatment for nonalcoholic fatty liver disease.
- A national collaboration to disseminate skills for outpatient teaching in internal medicine: program description and preliminary evaluation.
- Racial and socioeconomic differences in the weight-loss experiences of obese women.
- Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
- Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.
- Outcomes of a national faculty development program in teaching skills: prospective follow-up of 110 medicine faculty development teams.
- Serum ferritin and risk of the metabolic syndrome in U.S. adults.
- Dietary composition and nonalcoholic fatty liver disease.
- Faculty development needs.
- Negative trials in nonalcoholic steatohepatitis: why they happen and what they teach us.
- Teaching the teachers: national survey of faculty development in departments of medicine of U.S. teaching hospitals.
- Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness.
- Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.
- The prevalence and etiology of elevated aminotransferase levels in the United States.
- For the patient. Community health workers help to reduce high blood pressure.
- The effectiveness of a community/academic health center partnership in decreasing the level of blood pressure in an urban African-American population.
- Defining nonalcoholic fatty liver disease: implications for epidemiologic studies.
- Hepatic steatosis and type 2 diabetes mellitus.
- Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
- Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
- Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
- Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.
- Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
- Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?
- Weight loss strategies associated with BMI in overweight adults with type 2 diabetes at entry into the Look AHEAD (Action for Health in Diabetes) trial.
- Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program.
- Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy.
- Variation in Provider Identification of Obesity by Individual- and Neighborhood-Level Characteristics among an Insured Population.
- Independent but coordinated trials: insights from the practice-based Opportunities for Weight Reduction Trials Collaborative Research Group.
- Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
- Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
- Measurement of weight in clinical trials: is one day enough?
- Hepatic 31P magnetic resonance spectroscopy: a hepatologist''s user guide.
- Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.
- Factors associated with palliative care knowledge among internal medicine house staff.
- Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data.
- Effectiveness of an Activity Tracker- and Internet-Based Adaptive Walking Program for Adults: A Randomized Controlled Trial.
- Longitudinal Accuracy of Web-Based Self-Reported Weights: Results From the Hopkins POWER Trial.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Dartmouth Hitchcock Med Center
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Dartmouth-Hitchcock Medical Center -
Rutgers Robert Wood Johnson Medical School
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1780636688 | |
| NPPES Provider LastName | CLARK | |
| NPPES Provider FirstName | JEANNE | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 386.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 27.0 | |
| Percent Opioid Claims | 6.99 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780636688 |
| Last Name Of The Provider | CLARK |
| First Name Of The Provider | JEANNE |
| View All |
Similar Doctors
|
|
Dr. Madhav Goyal, MD |
|
|
Dr. Inna Gendelsman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Himani Shishodia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter S. Greene, MD |
|
|
Dr. Charles Angell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manuel V. Ramos Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc I. Leavey, MD
This Doctor is OpenDoctor Recommended.
|